Free Trial

HLS Therapeutics (HLS) Competitors

HLS Therapeutics logo
C$4.65 -0.06 (-1.27%)
As of 05/22/2025 03:54 PM Eastern

HLS vs. TLRY, ACB, WEED, FIRE, EPI, OGI, ICC, CPH, RIV, and LEAF

Should you be buying HLS Therapeutics stock or one of its competitors? The main competitors of HLS Therapeutics include Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), ICC Labs (ICC), Cipher Pharmaceuticals (CPH), RIV Capital (RIV), and Leaf Mobile (LEAF). These companies are all part of the "drug manufacturers - specialty & generic" industry.

HLS Therapeutics vs.

Tilray Brands (TSE:TLRY) and HLS Therapeutics (TSE:HLS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, community ranking, valuation, earnings, dividends and media sentiment.

HLS Therapeutics received 34 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 64.15% of users gave HLS Therapeutics an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%
HLS TherapeuticsOutperform Votes
34
64.15%
Underperform Votes
19
35.85%

HLS Therapeutics has lower revenue, but higher earnings than Tilray Brands. HLS Therapeutics is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$610.34M0.65-C$183.24M-C$0.41-1.50
HLS TherapeuticsC$40.13M2.58-C$15.53M-C$1.00-4.66

Tilray Brands has a beta of 2.19, indicating that its stock price is 119% more volatile than the S&P 500. Comparatively, HLS Therapeutics has a beta of 1.07, indicating that its stock price is 7% more volatile than the S&P 500.

11.2% of Tilray Brands shares are owned by institutional investors. Comparatively, 65.2% of HLS Therapeutics shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Comparatively, 0.4% of HLS Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Tilray Brands has a net margin of -30.02% compared to HLS Therapeutics' net margin of -38.70%. Tilray Brands' return on equity of -7.24% beat HLS Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-30.02% -7.24% -1.41%
HLS Therapeutics -38.70%-25.27%-2.89%

HLS Therapeutics has a consensus price target of C$4.50, indicating a potential downside of 3.23%. Given HLS Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe HLS Therapeutics is more favorable than Tilray Brands.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
HLS Therapeutics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, HLS Therapeutics had 2 more articles in the media than Tilray Brands. MarketBeat recorded 3 mentions for HLS Therapeutics and 1 mentions for Tilray Brands. HLS Therapeutics' average media sentiment score of 1.12 beat Tilray Brands' score of 0.59 indicating that HLS Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
HLS Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

HLS Therapeutics beats Tilray Brands on 9 of the 17 factors compared between the two stocks.

Get HLS Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLS vs. The Competition

MetricHLS TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$103.45MC$2.15BC$5.33BC$5.94B
Dividend Yield4.30%2.92%5.21%6.32%
P/E Ratio-4.663.9526.7529.92
Price / Sales2.58523.09392.41823.31
Price / Cash15.2210.2538.2583.71
Price / Book1.856.916.773.99
Net Income-C$15.53MC$20.70BC$3.23BC$301.32M
7 Day Performance-3.12%-0.95%0.43%0.43%
1 Month Performance10.45%3.26%9.07%6.45%
1 Year Performance19.85%94.40%18.59%17.05%

HLS Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLS
HLS Therapeutics
0.5939 of 5 stars
C$4.65
-1.3%
C$4.50
-3.2%
+20.8%C$103.45MC$40.13M-4.6691Positive News
TLRY
Tilray Brands
N/AC$0.63
-7.4%
N/A-75.8%C$405.95MC$610.34M-1.522,650Gap Up
ACB
Aurora Cannabis
0.7925 of 5 stars
C$7.42
+3.6%
C$8.75
+17.9%
-18.9%C$405.94MC$195.83M-9.161,073
WEED
Canopy Growth
1.4823 of 5 stars
C$2.43
+6.1%
C$5.64
+132.0%
-79.1%C$390.91MC$519.68M-0.352,700Positive News
Gap Up
High Trading Volume
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
OGI
Organigram
3.1366 of 5 stars
C$1.88
+0.5%
C$3.33
+76.9%
-26.2%C$232.26MC$180.58M-3.97987Positive News
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533,684.0095.29N/AGap Up
CPH
Cipher Pharmaceuticals
1.6185 of 5 stars
C$12.38
-0.8%
C$14.75
+19.1%
+38.0%C$222.26MC$19.03M13.675
RIV
RIV Capital
N/AN/AN/AN/AC$213.65MC$11.33M-1.6312
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150

Related Companies and Tools


This page (TSE:HLS) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners